Allan Shaw

Allan Lee Shaw was the founder of Shaw Strategic Capital LLC, founded in 2005, where the title held was Senior Managing Director from 2005 to 2009.
Current jobs include Director at CalciMedica Subsidiary, Inc. since 2021; Director at Edith & Carl Marks Jch of Bensonhurst; Director at Evecxia, Inc. since 2023; Independent Director at CalciMedica, Inc. since 2023; Member of The American Institute of Certified Public Accountants; Member of New York State Society of Certified Public Accountants; and Member of Corporate Directors Group.
Former jobs include Director at Viatel, Inc. from 1996 to 2002; Independent Director at VIVUS, Inc. from 2015 to 2019; Managing Director at Alvarez & Marsal LLC from 2011 to 2015; Chief Financial Officer & Executive Director at NewLead Holdings Ltd. from 2009 to 2011; Director at Celsus Therapeutics Plc in 2013; Director at Navios Maritime Holdings, Inc. from 2005 to 2010; Independent Director at Akari Therapeutics Plc from 2013 to 2016; Director at Central New York Biotech Accelerator from 2009 to 2013; Independent Non-Executive Director at Blue Water Biotech, Inc. from 2020 to 2022; Chief Financial Officer, Secretary & Treasurer at Syndax Pharmaceuticals, Inc. from 2016 to 2017; Chief Financial Officer at Serono SA from 2002 to 2004; Manager at Deloitte & Touche LLP; Chief Financial Officer at Merck Serono SA; and Chief Financial Officer at AlphaTON Capital Corp.
Education includes undergraduate degree from State University of New York College at Oswego, conferred in 1986.